MONCYTE Health Appoints Dr. Nicholas Leeper as Chair of the Board
https://i0.wp.com/moncytehealth.com/wp-content/uploads/2024/10/One_line_drawing_of_platelets_4-scaled.jpg?fit=2560%2C1435&ssl=1
2560
1435
MONCYTE Health
https://i0.wp.com/moncytehealth.com/wp-content/uploads/2024/10/One_line_drawing_of_platelets_4-scaled.jpg?fit=2560%2C1435&ssl=1
Our latest news
MONCYTE Health at the American Heart Association (AHA) Scientific Sessions 2025
https://i0.wp.com/moncytehealth.com/wp-content/uploads/2025/01/Blogi_FH_Early_funding_news_08012024-1.png?fit=1280%2C720&ssl=1
1280
720
MONCYTE Health
https://i0.wp.com/moncytehealth.com/wp-content/uploads/2025/01/Blogi_FH_Early_funding_news_08012024-1.png?fit=1280%2C720&ssl=1
MONCYTE Health at the American Heart Association (AHA) Scientific Sessions 2025
MONCYTE Health Showcases Finnish Health Innovation at HLTH USA 2025 in Las Vegas
https://i0.wp.com/moncytehealth.com/wp-content/uploads/2025/06/header_ATVB_blog.jpg?fit=1920%2C1076&ssl=1
1920
1076
MONCYTE Health
https://i0.wp.com/moncytehealth.com/wp-content/uploads/2025/06/header_ATVB_blog.jpg?fit=1920%2C1076&ssl=1
MONCYTE Health Showcases Finnish Health Innovation at HLTH USA 2025 in Las Vegas
Technology
A novel personalized diagnostic test for optimal cholesterol-lowering therapy.
MONCYTE Health technology can optimize treatment and prevention of cardiovascular disease. It is designed to help clinicians select more effective personalized treatments for patients with high cholesterol.
Our Team
Simon Pfisterer PhD
CSO & founder
Tamara Alagirova
CEO & founder
Iris Lähdeniemi PhD
Laboratory & Data Manager
Siina Pamilo DSc
Data Scientist
Marc Sundén MSc
Laboratory Technician
Sponsors & Partners
